Nuclear Expression Loss of SSBP2 Is Associated with Poor Prognostic Factors in Colorectal Adenocarcinoma.

Although patients with a lower expression of SSBP2 potentially have a poorer OS and DFS, they did not reach statistical significance (median OS, 29.8 months vs. 42.3 months for a low and high expression, respectively, HR 1.886, 95% CI 0.812–4.378, p = 0.140; median DFS, 14 months vs. 30 months for a low and high expression, respectively; HR 1.913; 95% CI, 0.825–4.437; p = 0.131) [ 27 ].

also in 111,027 other papers